Halozyme Therapeutics (HALO) – Hot Corp. News
-
Halozyme Therapeutics (HALO) Acquires Antares Pharma (ATRS) for $5.60/sh or $960M
-
Halozyme Therapeutics (HALO) Reports HALO-301 Phase 3 Study Fails To Meet Primary Endpoint
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to HALO Stock Lookup